FADS2 and central nervous system cancer: Based on The Human Protein Atlas (available from http://www.proteinatlas.org), the greater expression of FADS1 and FADS2 genes in a glioma increases the 3-year survival of patients (p = 0.0045 for FADS1, p = 0.030 for FADS2) [65,80,81].